BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 26303101)

  • 1. Tear Cytokines as Biomarkers for Chronic Graft-versus-Host Disease.
    Jung JW; Han SJ; Song MK; Kim TI; Kim EK; Min YH; Cheong JW; Seo KY
    Biol Blood Marrow Transplant; 2015 Dec; 21(12):2079-2085. PubMed ID: 26303101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokines in tear fluid of patients with ocular graft-versus-host disease after allogeneic stem cell transplantation.
    Riemens A; Stoyanova E; Rothova A; Kuiper J
    Mol Vis; 2012; 18():797-802. PubMed ID: 22509110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers in Ocular Chronic Graft Versus Host Disease: Tear Cytokine- and Chemokine-Based Predictive Model.
    Cocho L; Fernández I; Calonge M; Martínez V; González-García MJ; Caballero D; López-Corral L; García-Vázquez C; Vázquez L; Stern ME; Enríquez-de-Salamanca A
    Invest Ophthalmol Vis Sci; 2016 Feb; 57(2):746-58. PubMed ID: 26927568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation Between Tear Film Osmolarity and the Disease Score of the International Chronic Ocular Graft-Versus-Host-Disease Consensus Group in Hematopoietic Stem Cell Transplantation Patients.
    Schargus M; Meyer-ter-Vehn T; Menrath J; Grigoleit GU; Geerling G
    Cornea; 2015 Aug; 34(8):911-6. PubMed ID: 26075459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical "cytokine storm" as revealed by monocyte intracellular flow cytometry: correlation of tumor necrosis factor alpha with severe gut graft-versus-host disease.
    Fowler DH; Foley J; Whit-Shan Hou J; Odom J; Castro K; Steinberg SM; Gea-Banacloche J; Kasten-Sportes C; Gress RE; Bishop MR
    Clin Gastroenterol Hepatol; 2004 Mar; 2(3):237-45. PubMed ID: 15017608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prehematopoietic Stem Cell Transplantation Tear Cytokines as Potential Susceptibility Biomarkers for Ocular Chronic Graft-Versus-Host Disease.
    Cocho L; Fernández I; Calonge M; Sainz de la Maza M; Rovira M; Stern ME; Garcia-Vazquez C; Enríquez-de-Salamanca A
    Invest Ophthalmol Vis Sci; 2017 Sep; 58(11):4836-4846. PubMed ID: 28973330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tear Osmolarity and Ocular Surface Parameters as Diagnostic Markers of Ocular Graft-Versus-Host Disease.
    Na KS; Yoo YS; Hwang KY; Mok JW; Joo CK
    Am J Ophthalmol; 2015 Jul; 160(1):143-9.e1. PubMed ID: 25870935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical study of the cytokine panel in the diagnosis of ocular chronic graft-versus-host disease].
    Cheng XJ; Ji R; Huan RH; Huang SQ; Fan W; Zhao YC; Yuan RD; Wang XQ; Zhang X
    Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):242-248. PubMed ID: 38716595
    [No Abstract]   [Full Text] [Related]  

  • 9. Cytokine Profile of Engraftment Syndrome in Pediatric Hematopoietic Stem Cell Transplant Recipients.
    Khandelwal P; Mellor-Heineke S; Rehman N; Lane A; Smiley K; Villanueva J; Marsh RA; Grimley MS; Davies SM; Filipovich AH
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):690-697. PubMed ID: 26740373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tear cytokine levels in the diagnosis and severity assessment of ocular chronic graft-versus-host disease(GVHD).
    Hu B; Qiu Y; Hong J
    Ocul Surf; 2020 Apr; 18(2):298-304. PubMed ID: 31954196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of National Institutes of Health global scoring system for chronic graft-versus-host disease (GVHD) according to overall and GVHD-specific survival.
    Moon JH; Sohn SK; Lambie A; Ellis L; Hamad N; Uhm J; Gupta V; Lipton JH; Messner HA; Kuruvilla J; Kim D
    Biol Blood Marrow Transplant; 2014 Apr; 20(4):556-63. PubMed ID: 24447907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum cytokine levels in bone marrow transplantation: synergistic interaction of interleukin-6, interferon-gamma, and tumor necrosis factor-alpha in graft-versus-host disease.
    Imamura M; Hashino S; Kobayashi H; Kubayashi S; Hirano S; Minagawa T; Tanaka J; Fujii Y; Kobayashi M; Kasai M
    Bone Marrow Transplant; 1994 Jun; 13(6):745-51. PubMed ID: 7920309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers in Ocular Graft-Versus-Host Disease: Implications for the Involvement of B Cells.
    Shen Z; Ma J; Peng R; Hu B; Zhao Y; Liu S; Hong J
    Transplant Cell Ther; 2022 Nov; 28(11):749.e1-749.e7. PubMed ID: 35914728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of International Chronic Ocular Graft-Versus-Host Disease (GVHD) Group Diagnostic Criteria as a Chronic Ocular GVHD-Specific Metric.
    Rapoport Y; Freeman T; Koyama T; Engelhardt BG; Jagasia M; Savani BN; Tran U; Kassim AA
    Cornea; 2017 Feb; 36(2):258-263. PubMed ID: 28060078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tear inflammatory mediators and protein in eyes of post allogenic hematopoeitic stem cell transplant patients.
    Nair S; Vanathi M; Mahapatra M; Seth T; Kaur J; Velpandian T; Ravi A; Titiyal JS; Tandon R
    Ocul Surf; 2018 Jul; 16(3):352-367. PubMed ID: 29723628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of serum cytokines after allogeneic bone marrow transplantation: interleukin-5 as a potential marker of acute graft-versus-host disease.
    Imoto S; Oomoto Y; Murata K; Das H; Murayama T; Kajimoto K; Sugimoto T; Gomyo H; Nakagawa T; Nishimura R; Koizumi T
    Int J Hematol; 2000 Jul; 72(1):92-7. PubMed ID: 10979216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Prosthetic Replacement of the Ocular Surface Ecosystem Scleral Lenses in Patients with Ocular Chronic Graft-versus-Host Disease.
    Theophanous C; Irvine JA; Parker P; Chiu GB
    Biol Blood Marrow Transplant; 2015 Dec; 21(12):2180-2184. PubMed ID: 26234721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine profiles in various graft-versus-host disease target organs following hematopoietic stem cell transplantation.
    Lai HY; Chou TY; Tzeng CH; Lee OK
    Cell Transplant; 2012; 21(9):2033-45. PubMed ID: 22840591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of graft-versus-host disease: a biomarker panel based on lymphocytes and cytokines.
    Budde H; Papert S; Maas JH; Reichardt HM; Wulf G; Hasenkamp J; Riggert J; Legler TJ
    Ann Hematol; 2017 Jul; 96(7):1127-1133. PubMed ID: 28447161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Th1 and Th17 cytokines drive inflammation in Takayasu arteritis.
    Saadoun D; Garrido M; Comarmond C; Desbois AC; Domont F; Savey L; Terrier B; Geri G; Rosenzwajg M; Klatzmann D; Fourret P; Cluzel P; Chiche L; Gaudric J; Koskas F; Cacoub P
    Arthritis Rheumatol; 2015 May; 67(5):1353-60. PubMed ID: 25604824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.